Prevail Therapeutics Inc (NASDAQ:PRVL)

North American company
add to virtual portfolio
trade
discuss
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - PRVL

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - PRVL

  • Market Cap$362.680m
  • SymbolNASDAQ:PRVL
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS74140Y1010

Company Profile

Prevail Therapeutics Inc is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. Its pipeline products include PR001, PR006 and PR 004.

Latest PRVL news

Currently there for this company. Visit our news hub for other news .